+ Yes for most people on GLP-1 medications, proactive vitamin D3 supplementation is strongly advisable
Mechanism of Action Retatrutide is a GGG (GLP-1/GIP/Glucagon) tri-agonist, simultaneously activating three key metabolic receptors: GLP-1 Receptor: Stimulates glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite, contributing to glycemic control and weight reduction
Treat the gap between them as indicative rather than precise
Instead, consult with your healthcare provider to discuss a safe and gradual discontinuation plan that supports your long-term health goals
This is a different approach entirely, combining a GLP-1 agonist with an amylin receptor agonist rather than adding GIP or glucagon
Inform your health care providers of palpitations or feelings of a racing heartbeat while at rest during therapy